Bristol Myers Squibb - SystImmune and Bristol Myers Squibb Announce a Global Strategic Collaboration Agreement for the Development and Commercialization of BL-B01D1 (bms.com) SystImmune and Bristol Myers Squibb Announce a Global Strategic Collaboration Agreement for the Development and Commercialization of BL-B01D1 SystImmune and Bristol Myers Squibb to co-develop and co-commercialize BL-B01D1 in the United States; SystImmune to retain exclusive rights in Mainland China and Bristol Myers Squibb ...
#
ADC
#
BMS
#
EGFR
#
HER3
#
SystImmune
#
이중항체ADC
원문 링크 : BMS, 이중항체 ADC licence in
